18 results
8-K
EX-99.1
NGM
Ngm Biopharmaceuticals Inc
4 Apr 23
Cost Associated with Exit or Disposal Activities
4:06pm
-Long has built a scientific leadership team more than capable of continuing our track record of innovation. With Jin-Long’s departure, I am pleased
8-K
EX-99.1
jmpx118uo2wydu li4t
12 Nov 20
NGM Bio Provides Business Highlights and Reports Third Quarter 2020 Financial Results
4:32pm
10-K
8hjoaji eixf
17 Mar 20
Annual report
4:33pm
424B1
e7951dkg3vjwi
4 Apr 19
Prospectus with pricing info
5:21pm
S-1/A
xbsjcd8w32k48owudiol
25 Mar 19
IPO registration (amended)
12:00am
S-1
hfgce96 315mgmtavvg9
28 Sep 18
IPO registration
5:14pm
S-1
EX-10.15
d72ntn48ipx48ks07w
28 Sep 18
IPO registration
5:14pm
DRS
k6ljorlnlhg3l68x5wb
10 Aug 18
Draft registration statement
12:00am
DRS
EX-10.15
7v5kphdsixci
10 Aug 18
Draft registration statement
12:00am
- Prev
- 1
- Next